Medicare Part D data: A valuable tool for pharmacoepidemiology and pharmacoeconomic research

Risk of Mortality in Elderly Nursing Home Patients with Depression Using Paroxetine

“…The Medicare Provider Analysis and Review file (Part A), carrier file (Part B), the prescription claims file (Part D), the MDS, and the Master Beneficiary Summary File (MBSF) along with its chronic condition (CC) segment were used in this study. The CC segment contains information from inpatient and outpatient claims data on 27 common CCs . The study cohort included depressed elderly Medicare beneficiaries with a MDS assessment during the study period.…”

Risk of Cognitive Decline Associated With Paroxetine Use in Elderly Nursing Home Patients With Depression

“…23 The MDS is a standardized, primary screening and assessment tool for clinical assessment of all residents in federally certified nursing home facilities. 24…”

“…23 The MDS is a standardized, primary screening and assessment tool for clinical assessment of all residents in federally certified nursing home facilities. 24 All Medicare-certified nursing homes are required to complete a comprehensive MDS annual assessment on each resident upon admission and when the resident shows significant change in patient health status. A subset of the full MDS assessment is conducted quarterly.…”

Comparative Effectiveness of Second-Generation Antidepressants in Reducing the Risk of Dementia in Elderly Nursing Home Residents with Depression

“…The study used multiyear 2007–2010, multistate Minimum Data Set (MDS)‐linked Medicare data files obtained from the Centers for Medicare and Medicaid Services Chronic Condition Data Warehouse (CCW) . Medicare Part A provides hospital coverage, and supplementary medical insurance is offered through Part B. Medicare Part D provides prescription benefits to Medicare beneficiaries . The MDS is a national standardized assessment tool that forms the foundation of a comprehensive assessment of all residents in federally certified nursing home facilities .…”